Belén Garijo, Chair of the Executive Board and CEO of Merck, shared a post by Sanofi on LinkedIn, adding:
“Proud of Sanofi as the first pharma company to publicly report co-created patient metrics with 80+ patient organizations worldwide. I have always believed that trust is earned through actions. And in healthcare, trust is key, because the people we serve are counting on us at the most vulnerable moments of their lives.
To every patient advocate, healthcare leader, and industry colleague: I invite you to explore what we’ve learned.”
Quoting Sanofi‘s post:
“Three years ago, we made a set of commitments to the patient community. Today, we’re delivering.
Our 2025 Patient Community Promise Report shows real progress:
- 100% of our clinical studies informed directly by patients
- Patient satisfaction in ease of working together increased from 61% to 91%
- Patient-relevant drug label strategy implemented in 100% of Phase 3 programs
We were the first pharma company to publicly report these metrics, co-created with more than 80 patient organizations worldwide.
And we are going beyond numbers:
- More than 20 local impact highlights across 11+ disease areas
- Fully digital and accessible experience
- More than 25 performance metrics involving 8 core functions
Working for patients was never enough. We work with them. And that changes everything.
Read the 2025 Patient Community Promise Report.”
Other articles featuring Belén Garijo on OncoDaily.